Related Experiment Video
Updated: Aug 24, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Elevated pulse pressure during the acute period of ischemic stroke is associated with poor stroke outcome
Stella Aslanyan1, Christopher J Weir, Kennedy R Lees
1Division of Cardiovascular and Medical Sciences, University of Glasgow, Scotland. stella_s_aslanyan@hotmail.com
Insights
Elevated pulse pressure (PP), the difference between systolic and diastolic blood pressure, is linked to worse outcomes after an ischemic stroke. This finding helps identify stroke patients at higher risk for poor recovery.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Clinical Trials
Background:
- The predictive value of specific blood pressure components for acute stroke outcomes remains debated.
- This study investigates whether elevated pulse pressure (PP) independently predicts poor stroke outcomes.
Purpose of the Study:
- To determine the association between elevated pulse pressure and 3-month outcomes in ischemic stroke patients.
- To clarify the role of PP as a prognostic marker in acute stroke.
Main Methods:
- Analysis of 1455 ischemic stroke cases from the GAIN International trial.
- Utilized Cox proportional hazards and logistic regression, adjusting for multiple clinical and demographic factors.
Main Results:
- Elevated weighted average PP within 60 hours correlated with increased mortality and poorer scores on Barthel index, NIHSS, and Rankin scales.
- Elevated baseline PP was associated with worse Barthel index and Rankin scores.
Conclusions:
- Elevated pulse pressure is an independent predictor of poor stroke outcome at 3 months.
- PP measurement may aid in risk stratification for ischemic stroke patients.
Background:
It is controversial which component of blood pressure (BP) during acute period of stroke best predicts outcome. We hypothesized that elevated pulse pressure (PP), the difference between systolic BP (SBP) and diastolic BP (DBP), is independently associated with poor stroke outcome at 3 months.
Methods:
We analyzed both treatment groups from the Glycine Antagonist (Gavestinel) in Neuroprotection (GAIN) International trial (1455 ischemic stroke cases of mostly moderate severity). Cox proportional hazards and logistic regression modeling corrected for demography, medical history, heart rate, stroke severity, and clinical subtype.
Results:
Elevated weighted average PP during the first 60 hours was associated with poor outcome by mortality, Barthel index, National Institutes of Health Stroke Score (NIHSS) and Rankin scores. Elevated baseline PP was associated with Barthel index and Rankin score.
Conclusions:
Elevated PP is associated with poor stroke outcome at 3 months.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Pulse
The pulse serves as a clinical indicator...
Blood Pressure
Measurement of Blood Pressure
Transient Ischemic Attack l: Introduction
